CONMED CorpCNMDEarnings & Financial Report
The CONMED Corporation is a publicly traded American manufacturer of medical equipment and surgical devices, primarily in the orthopedic, laparoscopic and general surgery, and patient care areas. CONMED's headquarters is in Largo, Florida. Prior to July 2022, it was in Utica, New York. CONMED embraces a people-first culture that starts with a mission to support their healthcare partners and the patients they serve. They have manufacturing facilities in the United States and Mexico, offices in...
CNMD Q1 FY2026 Key Financial Metrics
Revenue
$317.0M
Gross Profit
$183.4M
Operating Profit
$25.4M
Net Profit
$13.8M
Gross Margin
57.9%
Operating Margin
8.0%
Net Margin
4.4%
YoY Growth
-1.3%
EPS
$0.45
CONMED Corp Q1 FY2026 Financial Summary
CONMED Corp reported revenue of $317.0M (down 1.3% YoY) for Q1 FY2026, with a net profit of $13.8M (up 129.1% YoY) (4.4% margin). Cost of goods sold was $133.6M, operating expenses totaled $158.0M.
Key Financial Metrics
| Total Revenue | $317.0M |
|---|---|
| Net Profit | $13.8M |
| Gross Margin | 57.9% |
| Operating Margin | 8.0% |
| Report Period | Q1 FY2026 |
CONMED Corp Annual Revenue by Year
CONMED Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4B).
CONMED Corp Quarterly Revenue & Net Profit History
CONMED Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $317.0M | -1.3% | $13.8M | 4.4% |
| Q4 FY2025 | $373.2M | +7.9% | N/A | N/A |
| Q3 FY2025 | $337.9M | +6.7% | $2.9M | 0.8% |
| Q2 FY2025 | $342.3M | +3.1% | $21.4M | 6.3% |
| Q1 FY2025 | $321.3M | +2.9% | $6.0M | 1.9% |
| Q4 FY2024 | $345.9M | +5.8% | N/A | N/A |
| Q3 FY2024 | $316.7M | +4.0% | $49.0M | 15.5% |
| Q2 FY2024 | $332.1M | +4.5% | $30.0M | 9.0% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $332.1M | $316.7M | $345.9M | $321.3M | $342.3M | $337.9M | $373.2M | $317.0M |
| YoY Growth | 4.5% | 4.0% | 5.8% | 2.9% | 3.1% | 6.7% | 7.9% | -1.3% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.29B | $2.32B | $2.31B | $2.30B | $2.33B | $2.32B | $2.33B | N/A |
| Liabilities | $1.40B | $1.38B | $1.34B | $1.32B | $1.33B | $1.31B | $1.29B | N/A |
| Equity | $881.8M | $932.9M | $962.7M | $977.6M | $1.00B | $1.01B | $1.03B | N/A |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $43.3M | $51.2M | $43.3M | $41.5M | $29.1M | $53.7M | $46.3M |